Hologic Receives CE Mark to Use Saliva Samples with Aptima SARS-CoV-2 Test in EU

 Hologic Receives CE Mark to Use Saliva Samples with Aptima SARS-CoV-2 Test in EU

Hologic Receives CE Mark to Use Saliva Samples with Aptima SARS-CoV-2 Test in EU

Shots:

  • The company has received a CE Mark for the use of saliva samples with the Aptima SARS-CoV-2 assay in the EU. The test runs on the fully automated Panther system
  • The Aptima SARS-CoV-2 assay also received a CE Mark for nasopharyngeal and nasal swabs along with additional specimen types
  • The company has broadened the manufacturing capability to produce Aptima tests in large quantities and has shipped 100M+ Aptima COVID-19 tests globally since 2020 and ~2,600 Panther systems have been installed in clinical diagnostic laboratories across the globe

Click here to read full press release/ article | Ref: Hologic | Image: Hologic

Tuba Khan

Tuba Khan is Senior Editor at PharmaShots. She is curious, creative, and passionate about recent updates and innovation in the Life sciences industry. She covers Biopharma, MedTech, and Digital health segments. Tuba also has an experience of digital and social media marketing and runs the campaigns independently. She can be contacted on tuba@pharmashots.com

Related post